-transparent.png){kind=logo}
A long-term immunogenicity study of a single dose live attenuated H2 strain hepatitis A vaccine is being conducted in healthy Indian children at KEM Hospital, Pune. 131 of the original 143 children vaccinated in 2004, were evaluated for anti-HAV antibodies 30 months post vaccination (2007). Seroprotective antibody levels >20 mIU/mL were demonstrated in 87.8 % subjects with an overall GMT of 92.02 mIU/mL. No hepatitis like illness was recorded in any of the subjects since vaccination.
Related Publications
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
April 2023,
Journal of travel medicine,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
January 2009,
Indian pediatrics,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
November 2011,
Vaccine,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
January 2007,
Vaccine,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
August 2009,
Zhongguo yi miao he mian yi,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
January 2015,
Human vaccines & immunotherapeutics,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
September 2015,
The Journal of infectious diseases,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
December 2016,
Human vaccines & immunotherapeutics,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
January 1983,
Developments in biological standardization,
Sheila Bhave, and
Ashish Bavdekar, and
Amita Sapru, and
Seema Bawangade, and
Anand Pandit
April 1991,
The Journal of infectious diseases,
